Literature DB >> 11902563

Epidemiology of breast cancer.

T J Key1, P K Verkasalo, E Banks.   

Abstract

Breast cancer is the commonest cause of cancer death in women worldwide. Rates vary about five-fold around the world, but they are increasing in regions that until recently had low rates of the disease. Many of the established risk factors are linked to oestrogens. Risk is increased by early menarche, late menopause, and obesity in postmenopausal women, and prospective studies have shown that high concentrations of endogenous oestradiol are associated with an increase in risk. Childbearing reduces risk, with greater protection for early first birth and a larger number of births; breastfeeding probably has a protective effect. Both oral contraceptives and hormonal therapy for menopause cause a small increase in breast-cancer risk, which appears to diminish once use stops. Alcohol increases risk, whereas physical activity is probably protective. Mutations in certain genes greatly increase breast-cancer risk, but these account for a minority of cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11902563     DOI: 10.1016/S1470-2045(00)00254-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  225 in total

1.  Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18.

Authors:  Karen A Gould; Martin Tochacek; Beverly S Schaffer; Tanya M Reindl; Clare R Murrin; Cynthia M Lachel; Eric A VanderWoude; Karen L Pennington; Lisa A Flood; Kimberly K Bynote; Jane L Meza; Michael A Newton; James D Shull
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

2.  Assessing patterns of practice of sentinel lymph node biopsy for breast cancer in Latin America.

Authors:  Sergio A Acuna; Fernando A Angarita; Jaime Escallon
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

3.  Geographic variations in female breast cancer incidence in relation to ambient air emissions of polycyclic aromatic hydrocarbons.

Authors:  Courtney Large; Yudan Wei
Journal:  Environ Sci Pollut Res Int       Date:  2017-06-14       Impact factor: 4.223

4.  Development and Psychometric Assessment of the Measure of Globalization Influence on Health Risk (MGIHR) Among Mexican Women with Breast Cancer.

Authors:  Jesse N Nodora; Scott C Carvajal; Rebeca Robles-Garcia; Francisco Páez Agraz; Adrian Daneri-Navarro; Maria Mercedes Meza-Montenegro; Luis Enrique Gutierrez-Millan; Maria Elena Martinez
Journal:  J Immigr Minor Health       Date:  2015-08

5.  Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India.

Authors:  Shilpi Chattopadhyay; Sarah Siddiqui; Md Salman Akhtar; Mohammad Zeeshan Najm; S V S Deo; N K Shukla; Syed Akhtar Husain
Journal:  Tumour Biol       Date:  2014-01-16

6.  Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses' Health Study.

Authors:  Renée T Fortner; Shelley S Tworoger; Tianying Wu; A Heather Eliassen
Journal:  Breast Cancer Res Treat       Date:  2013-09-18       Impact factor: 4.872

7.  Risk factors for breast cancer in a black population--the Barbados National Cancer Study.

Authors:  Barbara Nemesure; Suh-Yuh Wu; Ian R Hambleton; M Cristina Leske; Anselm J Hennis
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

8.  Bone fractures and incident epithelial ovarian cancer in a prospective cohort study.

Authors:  Kim N Danforth; Catherine Schairer; Arthur Schatzkin; James V Lacey
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

9.  Maternal hormones during early pregnancy: a cross-sectional study.

Authors:  Tianhui Chen; Eva Lundin; Kjell Grankvist; Anne Zeleniuch-Jacquotte; Marianne Wulff; Yelena Afanasyeva; Helena Schock; Robert Johansson; Per Lenner; Goran Hallmans; Goran Wadell; Paolo Toniolo; Annekatrin Lukanova
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

10.  Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.

Authors:  Nicholas B Berry; Meiyun Fan; Kenneth P Nephew
Journal:  Mol Endocrinol       Date:  2008-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.